GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hamlet BioPharma AB publ (XSAT:HAMLET B) » Definitions » Debt-to-Equity

Hamlet BioPharma AB publ (XSAT:HAMLET B) Debt-to-Equity : 0.00 (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Hamlet BioPharma AB publ Debt-to-Equity?

Hamlet BioPharma AB publ's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was kr0.00 Mil. Hamlet BioPharma AB publ's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was kr0.00 Mil. Hamlet BioPharma AB publ's Total Stockholders Equity for the quarter that ended in Mar. 2025 was kr53.82 Mil. Hamlet BioPharma AB publ's debt to equity for the quarter that ended in Mar. 2025 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Hamlet BioPharma AB publ's Debt-to-Equity or its related term are showing as below:

During the past 12 years, the highest Debt-to-Equity Ratio of Hamlet BioPharma AB publ was 2.18. The lowest was 2.18. And the median was 2.18.

XSAT:HAMLET B's Debt-to-Equity is not ranked *
in the Biotechnology industry.
Industry Median: 0.14
* Ranked among companies with meaningful Debt-to-Equity only.

Hamlet BioPharma AB publ Debt-to-Equity Historical Data

The historical data trend for Hamlet BioPharma AB publ's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hamlet BioPharma AB publ Debt-to-Equity Chart

Hamlet BioPharma AB publ Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 2.18 - - -

Hamlet BioPharma AB publ Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Hamlet BioPharma AB publ's Debt-to-Equity

For the Biotechnology subindustry, Hamlet BioPharma AB publ's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hamlet BioPharma AB publ's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hamlet BioPharma AB publ's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Hamlet BioPharma AB publ's Debt-to-Equity falls into.


;
;

Hamlet BioPharma AB publ Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Hamlet BioPharma AB publ's Debt to Equity Ratio for the fiscal year that ended in Jun. 2024 is calculated as

Hamlet BioPharma AB publ's Debt to Equity Ratio for the quarter that ended in Mar. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hamlet BioPharma AB publ  (XSAT:HAMLET B) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Hamlet BioPharma AB publ Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Hamlet BioPharma AB publ's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Hamlet BioPharma AB publ Business Description

Traded in Other Exchanges
Address
Klinikgatan 32, BMC D10, Lund, SWE, SE-222 42
Hamlet BioPharma AB publ is a pharmaceutical company engaged in the research and development of drugs used for curing cancer.

Hamlet BioPharma AB publ Headlines

No Headlines